 |
Catalogue |
 |
|
Main Products |
|
|
|
|
Products |
|
No. |
Product Name |
CAS No. |
Spec |
Price |
|
| MM0095.07 |
Omeprazole Imp. E (EP) |
176219-04-8 |
|
|
| MM0095.01 |
Omeprazole Imp. F (EP) |
125656-82-8 |
|
|
| MM0095.02 |
Omeprazole Imp. G (EP) |
125656-83-9 |
|
|
| MM0095.15 |
Omeprazole Imp. H (EP) |
863029-89-4 |
|
|
| MM0095.16 |
Omeprazole Imp. I (EP) |
158812-85-2 |
|
|
| MM0095.08 |
5-Methoxy-2-[[(3,5-dimethylpyridin-2-yl)methyl]sulphanyl]-1H-benzimidazole |
704910-89-4 |
|
|
| MM0095.19 |
5-Methoxy-2-[[(4-chloro-3,5-dimethylpyridin-2-yl)methyl]sulphanyl]-1H-benzimidazole |
220757-74-4 |
|
|
| MM0095.20 |
5-Methoxy-1,3-dihydrobenzimidazol-2-one |
2080-75-3 |
|
|
| MM0095.23 |
2-[[(4-Methoxy-3,5-dimethylpyridin-2-yl)-methyl]sulphinyl]-1H-benzimidazole |
73590-60-0 |
|
|
| MM0095.24 |
5-Methoxy-2-(4-methoxy-3,5-dimethylpyridin-2-yl)-1H-benzimidazole |
n/a |
|
|
| MM0252.00 |
Ondansetron Hydrochloride Dihydrate |
103639-04-9 |
|
|
| MM0252.09 |
Ondansetron |
99614-02-5 |
|
|
| MM0252.03 |
Ondansetron Imp. A (EP) |
153139-56-1 |
|
|
| MM0252.02 |
Ondansetron Imp. B (EP) |
1076198-52-1 |
|
|
| MM0252.01 |
Ondansetron Imp. C (EP) |
27387-31-1 |
|
|
| MM0252.04 |
Ondansetron Imp. D (EP) |
99614-64-9 |
|
|
| MM0015.02 |
Ondansetron Imp. E (EP) |
288-32-4 |
|
|
| MM0252.06 |
Ondansetron Imp. F (EP) |
693-98-1 |
|
|
| MM0252.07 |
Ondansetron Imp. G (EP) |
99614-03-6 |
|
|
| MM0252.08 |
Ondansetron Imp. H (EP) |
99614-14-9 |
|
|
|
|
|
